← DR REDDYS LABORATORIES LTD
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net Income | — | — | — | — | — | — | $45.1b | $55.7b | $56.5b | $42.9b | |
| Net Income From Continuing Operations | — | — | — | — | — | — | $45.1b | $55.7b | $57.2b | $42.5b | |
| Depreciation and amortization | $11.3b | $11.7b | $176.0m | $165.0m | $175.0m | $156.0m | $154.0m | $178.0m | $200.0m | $220.0m | |
| Amortization Cash Flow | — | — | — | — | — | — | — | $5.3b | $6.6b | $8.0b | |
| Amortization Of Intangibles | — | — | — | — | — | — | — | $5.3b | $6.6b | $8.0b | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $12.6b | $14.8b | $17.1b | $20.6b | |
| Deferred Income Tax | — | — | — | — | — | — | $15.3b | $16.2b | $19.5b | $12.4b | |
| Deferred Tax | — | — | — | — | — | — | $15.3b | $16.2b | $19.5b | $12.4b | |
| Adjustments For Share-Based Payments | — | $7.0m | $6.0m | $7.0m | $8.0m | $8.0m | $5.0m | $5.0m | $5.0m | — | |
| Impairment of non-current assets, net | $445.0m | $53.0m | $3.0m | $222.0m | $117.0m | $100.0m | $9.0m | $1.0m | $20.0m | $38.0m | |
| Equity settled share-based payment expense | $350.0m | $454.0m | $6.0m | $7.0m | $8.0m | $8.0m | $5.0m | $5.0m | $5.0m | $3.0m | |
| Asset Impairment Charge | — | — | — | — | — | — | $5.6b | $3.6b | $6.9b | $11.0b | |
| Adjustments For Income Tax Expense | — | $70.0m | $53.0m | ($19.0m) | $125.0m | $115.0m | $186.0m | $194.0m | $229.0m | — | |
| Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method | — | $984.0m | $1.1b | $1.5b | $1.1b | $1.0b | $1.4b | $1.6b | $3.3b | — | |
| Interest (income)/expense, net | $76.0m | $248.0m | $2.0m | $1.0m | $2.0m | $0 | $3.0m | ($7.0m) | $2.0m | $0 | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | ($370.0m) | ($147.0m) | ($217.0m) | ($134.0m) | |
| Additional Financial Items | |||||||||||
| Adjustments For Unrealised Foreign Exchange Losses Gains | — | ($5.0m) | ($23.0m) | ($29.0m) | $25.0m | ($10.0m) | ($11.0m) | ($6.0m) | $2.0m | — | |
| Goodwill | — | $61.0m | $56.0m | $53.0m | $62.0m | $58.0m | $52.0m | $51.0m | $138.0m | — | |
| Payments To Acquire Or Redeem Entitys Shares | — | $0 | $0 | — | — | $0 | — | — | — | — | |
| Proceeds From Borrowings Classified As Financing Activities | — | $66.6b | $42.9b | $29.8b | $48.3b | $51.5b | $49.2b | $19.4b | $80.6b | — | |
| Proceeds From Issuing Shares | — | $0 | $0 | — | — | — | — | — | — | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | — | $27.0m | $8.0m | $17.0m | $39.0m | $58.0m | $92.0m | $132.0m | $81.0m | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | $65.7b | $58.1b | $48.5b | $41.4b | $48.0b | $68.6b | $13.9b | $56.2b | — | |
| Profit for the year | $12.0b | $9.8b | $272.0m | $259.0m | $17.2b | $311.0m | $548.0m | $668.0m | $671.0m | $452.0m | |
| Tax expense, net | $2.6b | $4.5b | $53.0m | ($19.0m) | $125.0m | $115.0m | $186.0m | $194.0m | $229.0m | $132.0m | |
| Fair value changes and profit on sale of financial instruments measured at FVTPL, net | — | — | — | ($929.0m) | ($557.0m) | ($4.0m) | ($11.0m) | ($38.0m) | ($42.0m) | ($25.0m) | |
| Allowance for credit losses (on trade receivables and other advances) | — | $155.0m | $420.0m | $3.0m | $3.0m | $1.0m | $2.0m | $3.0m | $2.0m | $8.0m | |
| (Profit)/ Loss on sale/disposal of assets, net | — | — | — | $68.0m | $42.0m | ($15.0m) | $3.0m | ($11.0m) | ($18.0m) | ($27.0m) | |
| Share of profit of equity accounted investees | ($349.0m) | ($344.0m) | ($6.0m) | ($7.0m) | ($7.0m) | ($9.0m) | ($5.0m) | ($2.0m) | ($3.0m) | ($1.0m) | |
| Unrealized exchange (gain)/loss, net | $609.0m | ($296.0m) | ($23.0m) | ($29.0m) | $25.0m | ($10.0m) | ($11.0m) | ($6.0m) | $2.0m | ($6.0m) | |
| Inventories write-down | $3.1b | $2.9b | $4.0b | — | $2.5b | $4.6b | $59.0m | $43.0m | $61.0m | $80.0m | |
| Trade and other receivables | $3.0b | ($2.1b) | $26.0m | ($165.0m) | $28.0m | ($224.0m) | ($70.0m) | ($97.0m) | ($120.0m) | ($72.0m) | |
| Inventories | ($6.3b) | ($3.2b) | ($123.0m) | ($20.0m) | ($135.0m) | ($70.0m) | ($32.0m) | ($221.0m) | ($149.0m) | ($92.0m) | |
| Trade and other payables | $1.9b | $2.5b | $6.0m | $21.0m | $39.0m | $58.0m | $0 | $42.0m | $4.0m | $30.0m | |
| Other assets and other liabilities, net | ($3.9b) | ($6.1b) | $8.0m | $64.0m | ($45.0m) | $53.0m | $6.0m | $34.0m | ($85.0m) | $11.0m | |
| Cash generated from operations | $27.3b | $20.8b | $485.0m | $490.0m | $566.0m | $468.0m | $847.0m | $786.0m | $779.0m | $751.0m | |
| Purchase of other intangible assets | ($28.7b) | ($1.8b) | ($8.0m) | ($17.0m) | ($39.0m) | ($58.0m) | ($92.0m) | ($132.0m) | ($81.0m) | ($161.0m) | |
| Proceeds from sale of other intangible assets | — | $0 | $885.0m | $3.0m | $0 | $39.0m | $0 | $1.0m | $9.0m | $15.0m | |
| Payment for acquisition of businesses | ($17.0m) | $0 | $0 | — | ($15.5b) | ($4.0m) | $0 | $0 | ($622.0m) | ($34.0m) | |
| Investment in associates | ($86.0m) | $0 | $0 | — | — | $0 | $0 | ($1.0m) | ($4.0m) | ($1.0m) | |
| Proceeds from issuance of equity shares (including treasury shares) | $1.0m | $1.0m | $0 | $0 | $269.0m | $4.0m | $2.0m | $10.0m | $2.0m | $4.0m | |
| Purchase of treasury shares | $0 | $0 | ($8.0m) | ($6.0m) | ($16.0m) | $0 | $0 | $0 | ($16.0m) | $0 | |
| Proceeds from/(repayment of) short-term borrowings, net | $21.5b | ($18.0b) | ($219.0m) | $56.0m | $93.0m | $3.5b | ($236.0m) | $66.0m | $287.0m | $215.0m | |
| Proceeds from long-term borrowings (Refer to Note 16 for details) | — | — | — | — | $52.0m | $0 | $0 | $46.0m | $0 | $0 | |
| Repayment of long-term borrowings (Refer to Note 16 for details) | — | — | — | ($22.9b) | ($51.0m) | $0 | $0 | ($46.0m) | $0 | $0 | |
| Proceeds from issuance of equity shares in subsidiary comprising NCI (Refer to Note 35.A for details) | — | — | — | — | — | — | $0 | $0 | $83.0m | $0 | |
| Payment of principal portion of lease liabilities (Refer to Note 16 for details) | — | ($157.0m) | ($56.0m) | ($6.0m) | ($754.0m) | ($10.0m) | ($12.0m) | ($14.0m) | ($15.0m) | ($13.0m) | |
| Beginning Cash Position | — | — | — | — | — | — | $14.9b | $5.8b | $7.1b | $14.6b | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | ($26.9b) | ($3.8b) | $18.9b | $8.3b | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($41.4b) | ($40.3b) | ($58.1b) | ($65.5b) | |
| Change In Account Payable | — | — | — | — | — | — | — | — | $340.0m | $2.8b | |
| Change In Inventory | — | — | — | — | — | — | ($2.7b) | ($18.4b) | ($12.8b) | ($8.6b) | |
| Change In Other Working Capital | — | — | — | — | — | — | $528.0m | $2.9b | ($7.3b) | $897.0m | |
| Change In Payable | — | — | — | — | — | — | $23.0m | $3.5b | $340.0m | $2.8b | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $23.0m | $3.5b | $340.0m | $2.8b | |
| Change In Receivables | — | — | — | — | — | — | ($5.8b) | ($8.1b) | ($10.3b) | ($6.7b) | |
| Change In Working Capital | — | — | — | — | — | — | ($7.9b) | ($20.2b) | ($30.0b) | ($11.6b) | |
| Changes In Account Receivables | — | — | — | — | — | — | — | — | ($10.3b) | ($6.7b) | |
| Changes In Cash | — | — | — | — | — | — | ($9.4b) | $1.4b | $7.3b | ($468.0m) | |
| End Cash Position | — | — | — | — | — | — | $5.8b | $7.1b | $14.6b | $15.4b | |
| Financing Cash Flow | — | — | — | — | — | — | ($26.9b) | ($3.8b) | $18.9b | $8.3b | |
| Free Cash Flow | — | — | — | — | — | — | $40.0b | $18.0b | $12.0b | $18.3b | |
| Interest Received CFI | — | — | — | — | — | — | $777.0m | $1.3b | $3.4b | $1.5b | |
| Investing Cash Flow | — | — | — | — | — | — | ($41.4b) | ($40.3b) | ($58.1b) | ($65.5b) | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $368.0m | $805.0m | $193.0m | $397.0m | |
| Net Business Purchase And Sale | — | — | — | — | — | — | $0 | ($12.0m) | ($53.4b) | ($3.2b) | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | — | ($939.0m) | ($534.0m) | $211.0m | ($529.0m) | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | — | ($7.5b) | ($11.0b) | ($6.2b) | ($13.7b) | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($11.2b) | ($15.3b) | ($27.0b) | ($23.0b) | |
| Operating Gains Losses | — | — | — | — | — | — | ($1.1b) | ($1.6b) | ($1.5b) | ($3.2b) | |
| Other Non Cash Items | — | — | — | — | — | — | $248.0m | ($567.0m) | $152.0m | $12.0m | |
| Provisionand Write Offof Assets | — | — | — | — | — | — | $205.0m | $275.0m | $161.0m | $690.0m | |
| Purchase Of Business | — | — | — | — | — | — | $0 | ($12.0m) | ($53.4b) | ($3.2b) | |
| Purchase Of Intangibles | — | — | — | — | — | — | ($7.5b) | ($11.0b) | ($6.9b) | ($15.1b) | |
| Purchase Of PPE | — | — | — | — | — | — | ($11.3b) | ($16.4b) | ($27.5b) | ($23.3b) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | $0 | $0 | ($1.4b) | $0 | |
| Sale Of Intangibles | — | — | — | — | — | — | $0 | $21.0m | $732.0m | $1.4b | |
| Sale Of PPE | — | — | — | — | — | — | $82.0m | $1.1b | $512.0m | $309.0m | |
| Stock Based Compensation | — | — | — | — | — | — | $397.0m | $407.0m | $424.0m | $326.0m | |
| Unrealized Gain Loss On Investment Securities | — | — | — | — | — | — | ($876.0m) | ($3.1b) | ($3.6b) | ($2.4b) | |
| Profit or Loss | — | $151.0m | $272.0m | $259.0m | $236.0m | $311.0m | $548.0m | $668.0m | $671.0m | — | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $44.0m | $2.0m | $18.0m | $2.0m | $1.0m | $5.0m | $1.0m | $13.0m | $6.0m | $3.0m | |
| Purchase of property, plant and equipment | ($12.3b) | ($9.3b) | ($101.0m) | ($64.0m) | ($133.0m) | ($193.0m) | ($138.0m) | ($197.0m) | ($322.0m) | ($249.0m) | |
| Capital Expenditure Reported | — | — | — | — | — | ($19.0b) | ($18.9b) | — | — | — | |
| Purchase of other investments (including bank deposits) | ($49.7b) | ($68.4b) | ($1.1b) | ($1.5b) | ($1.0b) | ($1.2b) | ($1.7b) | ($1.7b) | ($3.0b) | ($498.0m) | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($23.4b) | ($15.7b) | $25.1b | ($27.1b) | |
| Purchase Of Investment | — | — | — | — | — | — | ($136.2b) | ($41.6b) | ($28.5b) | ($46.7b) | |
| Proceeds from sale of other investments (including bank deposits) | $71.6b | $64.0b | $1.1b | $1.5b | $1.1b | $1.0b | $1.4b | $1.6b | $3.3b | $209.0m | |
| Sale Of Investment | — | — | — | — | — | — | $112.8b | $25.9b | $53.6b | $19.6b | |
| Net cash used in investing activities | ($18.5b) | ($14.9b) | ($112.0m) | ($65.0m) | ($310.0m) | ($348.0m) | ($503.0m) | ($483.0m) | ($682.0m) | ($700.0m) | |
| Cash flows from financing activities: | |||||||||||
| Issuance Of Debt | — | — | — | — | — | — | $0 | $3.8b | $0 | $0 | |
| Long Term Debt Issuance | — | — | — | — | — | — | $0 | $3.8b | $0 | $0 | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | ($20.4b) | $4.3b | $23.2b | $19.0b | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | ($1.0b) | ($1.1b) | ($1.3b) | ($1.3b) | |
| Net Short Term Debt Issuance | — | — | — | — | — | — | ($19.4b) | $5.5b | $24.5b | $20.3b | |
| Short Term Debt Issuance | — | — | — | — | — | $3.5b | — | — | $24.5b | $20.3b | |
| Long Term Debt Payments | — | — | — | — | — | — | ($1.0b) | ($4.9b) | ($1.3b) | ($1.3b) | |
| Repayment Of Debt | — | — | — | — | — | — | ($1.0b) | ($4.9b) | ($1.3b) | ($1.3b) | |
| Common Stock Issuance | — | — | — | — | — | — | $368.0m | $805.0m | $193.0m | $397.0m | |
| Net Common Stock Issuance | — | — | — | — | — | — | $368.0m | $805.0m | ($1.2b) | $397.0m | |
| Common Stock Payments | — | — | — | — | — | — | $0 | $0 | ($1.4b) | $0 | |
| Dividends paid | — | $4k | $4k | $4k | $4k | $4k | $5k | $7k | $7k | — | |
| Dividends Paid Classified As Financing Activities | — | $61 | $58 | $52 | $57 | $55 | $61 | $80 | $78 | — | |
| Dividends Paid Ordinary Shares Per Share | — | $20.00 | $20.00 | — | — | — | — | — | — | — | |
| Dividend income | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Dividends received from equity accounted investees | — | $0 | $0 | $5.0m | — | $0 | $0 | $5.0m | $0 | $0 | |
| Interest and dividend received | $628.0m | $412.0m | $11.0m | $8.0m | $17.0m | $12.0m | $9.0m | $16.0m | $38.0m | $16.0m | |
| Dividend paid | ($3.4b) | ($4.0b) | ($58.0m) | ($52.0m) | ($57.0m) | ($55.0m) | ($61.0m) | ($80.0m) | ($78.0m) | ($71.0m) | |
| Cash Dividends Paid | — | — | — | — | — | — | ($5.0b) | ($6.6b) | ($6.7b) | ($6.7b) | |
| Dividends Received CFI | — | — | — | — | — | — | $0 | $445.0m | $0 | $0 | |
| Net cash from/(used) in financing activities | ($3.7b) | ($4.4b) | ($308.0m) | ($334.0m) | ($4.0m) | ($32.0m) | ($327.0m) | ($45.0m) | $222.0m | $88.0m | |
| Effect of exchange rate changes on cash and cash equivalents | ($492.0m) | $57.0m | $1.0m | $0 | $113.0m | $10.0m | $3.0m | ($1.0m) | $1.0m | $13.0m | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | $286.0m | ($59.0m) | $224.0m | $1.2b | |
| Net increase/(decrease) in cash and cash equivalents | ($650.0m) | ($1.3b) | ($5.0m) | ($3.0m) | $174.0m | ($9.0m) | ($114.0m) | $17.0m | $85.0m | ($5.0m) | |
| Cash and cash equivalents at the beginning of the year | $3.8b | $2.5b | $2.2b | $2.0b | $14.8b | $196.0m | $70.0m | $85.0m | $171.0m | $164.0m | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($9.4b) | $1.4b | $7.3b | ($468.0m) | |
| Interest Paid Classified As Financing Activities | ($925.0m) | $20.0m | $23.0m | $21.0m | $18.0m | $18.0m | $23.0m | $27.0m | $41.0m | ($47.0m) | |
| Income tax paid, net | ($5.8b) | ($2.8b) | ($70.0m) | ($94.0m) | ($78.0m) | ($98.0m) | ($130.0m) | ($241.0m) | ($234.0m) | ($144.0m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.